TriMas Q3 Adjusted EPS Rises to $0.50; 2026 Outlook Reaffirmed

TriMas Corp. (NASDAQ: TRS) reported higher third-quarter sales and a sharp improvement in earnings as cost reductions strengthened profitability, while production constraints and higher steel costs continued to weigh on its Specialty Products business. The company reaffirmed its full-year 2026 adjusted earnings guidance, though its margin outlook reflects extended throughput challenges at Norris Cylinder.

For the quarter ended September 30, net sales from continuing operations increased 7.7% to $178.7 million from $166.0 million a year earlier. Organic sales rose 7.2%, while favorable currency movements contributed another 0.5 percentage point.

Adjusted operating profit climbed 47.9% to $13.6 million, expanding the adjusted operating margin by 200 basis points to 7.6%. Adjusted diluted earnings per share increased to $0.50 from $0.17, supported by improved profitability, higher interest income and a lower share count.

On a GAAP basis, operating profit from continuing operations was $11.5 million, compared with a $3.2 million loss in the prior-year quarter. GAAP diluted earnings per share from continuing operations were $0.37, versus a loss of $0.12 per share.

For the first nine months of 2026, sales rose 6.4% to $521.6 million, including 4.7% organic growth and a 2% currency benefit. Adjusted operating profit increased 35.8% to $41.2 million, while adjusted EPS more than doubled to $1.25 from $0.51.

Packaging Growth Offsets Specialty Products Pressure

Packaging, TriMas’ largest segment, generated third-quarter sales of $147.6 million, up 8.8% year over year. Organic growth was 8.2%, reflecting higher demand across beauty and personal care, food and beverage, industrial, and life sciences applications.

Packaging adjusted operating profit rose 11.9% to $20.4 million, and its adjusted operating margin increased 40 basis points to 13.8%. The company attributed the improvement to higher volumes, cost reductions and operational initiatives. Adjusted EBITDA increased 3.6% to $28.3 million, although the adjusted EBITDA margin declined 90 basis points to 19.2%.

TriMas expects Packaging to deliver full-year sales growth of 4% to 5% and an operating margin of approximately 14%, including the anticipated effect of selling the Rapak flexible bag-in-box product line. The divestiture agreement is part of the company’s effort to streamline its portfolio and focus on core growth platforms.

Specialty Products sales increased 2.7% to $31.2 million, driven by stronger demand and market-share gains at Norris Cylinder. Those gains were partly constrained by production throughput issues.

Adjusted operating profit in the segment fell to $0.1 million from $2.4 million, while the adjusted operating margin contracted to 0.3% from 7.8%. TriMas said machine downtime, lower labor productivity and throughput constraints more than offset the benefit of higher volumes. Results were also affected by higher steel costs and a timing lag before those increases could be recovered through customer pricing.

The company expects Specialty Products sales to grow 7% to 10% for the full year, with operating margins of 4% to 6%. Management is implementing measures intended to improve throughput, machine utilization, labor productivity and cost efficiency.

Full-Year Earnings Outlook Maintained

TriMas reaffirmed its 2026 adjusted diluted EPS outlook of $1.60 to $1.70, compared with $0.55 in 2025. Its GAAP diluted EPS outlook from continuing operations is $1.06 to $1.13.

The company continues to expect full-year sales growth of 4% to 6% from a 2025 base of $645.7 million. Adjusted operating margin is expected to improve by approximately 250 basis points from 5.3% in 2025. TriMas said the margin outlook incorporates the extended operating challenges at Norris Cylinder, while cost reductions and other operational initiatives remain the primary expected drivers of improvement.

For the fourth quarter, TriMas expects year-over-year increases in sales, earnings and EPS. Interest income is projected at approximately $10 million, assuming no significant change in interest rates or redeployment of the proceeds from the TriMas Aerospace sale. Full-year interest expense is expected to be about $18 million, and the effective tax rate is forecast at 24% to 25%.

Corporate cash expenses are expected to decline by $11 million to $12 million from 2025 due to cost savings. Non-cash stock compensation is projected at $9 million to $10 million.

Aerospace Sale Strengthens Balance Sheet

Following the divestiture of TriMas Aerospace, the company ended September with cash and cash equivalents of $1.16 billion and total debt of $397.1 million, resulting in a net cash position of $761.4 million. The cash is being held in interest-bearing accounts until it is redeployed.

Adjusted free cash flow from continuing operations improved to $20.9 million in the third quarter from $4.0 million a year earlier, benefiting from working-capital performance and interest income. TriMas completed $183.8 million of share repurchases between the Aerospace divestiture announcement and the end of the third quarter and had repurchased more than 5.4 million shares since November 2025.

Management said its capital-allocation priorities include organic investment, targeted acquisitions in Packaging and Life Sciences, and shareholder returns. Execution risks include the continuing manufacturing constraints at Norris Cylinder, raw-material inflation, the timing of price recovery, supply-chain conditions and changing macroeconomic and tariff environments.